NCT06035679 2025-03-12Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast CancerFirst Affiliated Hospital of Fujian Medical UniversityPhase NA Recruiting30 enrolled